Disparities in disease burden and health outcomes result from the complex interaction of social, demographic, and biological factors, including genetic variations, differences in disease susceptibility, and varying responses to treatment across populations. Keystone Symposia’s Health Equity Series aims to highlight how researchers are integrating molecular, cellular, and genetic approaches into more inclusive research methodologies. Through panel discussions and short talks at select Keystone Symposia meetings, we explore how personalized medicine and patient-centered strategies that account for variability within human populations can enhance precision treatments and improve health outcomes for all.

See previews of VKS Health Disparities events below. Find more content at virtual.keystonesymposia.org.

2025 Health Equity Series

Health Equity Working Group